focus -WSS

focus

author：focus 2025-09-27 20:59:06 - browse：6856

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： What we need to know about Arena Bioworks

WSS

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Trump indictment: Who are the 'co

Novo Nordisk to expand supply of Wegovy for U.S. patients

5 important ways Henrietta Lacks changed medical science

Some dementia cases could be undiagnosed liver disease

Mitch McConnell episode has important public health takeaway

knowledge

focus

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Sage hopes for a blockbuster in antidepressant now before FDA

Guidelines to prevent youth baseball injuries need more muscle

Apple Vision Pro: A first look at health apps on the new VR headset

What does generative AI mean for health care? We asked experts

Commercial surrogacy can be ethical, despite pope’s claims

The high cost of giving birth even with insurance

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Dobbs anniversary: the lost opportunity of abortion as health care

Juul spent big to court Black leaders to promote its e

entertainment

Wildfire pollution widens asthma inequities on Long Island

Wildfire pollution widens asthma inequities on Long Island

Novo Nordisk to expand supply of Wegovy for U.S. patients

Scientists inch closer to single

Pence says 'crackpot lawyers' told Trump what he wanted to hear

The real point of Kenneth Smith’s execution by nitrogen gas

leisure time

hotspot

leisure time

focus